Takeda Pharmaceutical TAK
NYSE TAK
$18.48 -0.42 (-2.22%)
As of: Sep 29, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Current Assets (2017 - 2026)

Updated

Takeda Pharmaceutical's Current Assets came in at $19.76 billion for the quarter ended Jun 30, 2026, up 13.8% from $17.37 billion a year earlier and up 0.3% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Current Assets (2017 - 2026) Analysis & Trends

As of Mar 31, 2026, Takeda Pharmaceutical's Current Assets was $20.53 billion, up 24.0% from the prior year.

  • Current Assets carries a five-year compound annual growth rate of -4.3% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Current Assets was $16.55 billion in the year ended Mar 31, 2025 (-6.7%), $17.74 billion in the year ended Mar 31, 2024 (unchanged), $17.75 billion in the year ended Mar 31, 2023 (-23.2%) and $23.1 billion in the year ended Mar 31, 2022 (-9.7%).
  • The five-year range for quarterly Current Assets is $16.43 billion (the quarter ended Dec 31, 2023) to $22.32 billion (the quarter ended Mar 31, 2022).
  • Year-over-year, Current Assets has increased for three consecutive quarters, with growth averaging 6.8% over the last eight quarters.
  • The fastest year-over-year change in Current Assets over five years came in the quarter ended Sep 30, 2024 (growth of 20.1%), and the weakest in the quarter ended Mar 31, 2023 (a decline of 18.8%).
  • Business Quant data shows TAK's Current Assets at $19.71 billion (quarter ended Mar 31, 2026), $20.25 billion (quarter ended Dec 31, 2025) and $19.82 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Takeda Pharmaceutical 2.74 Bn -23.77 Bn 5.10 Bn 19.76 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.76 Bn
Mar 31, 2026 19.71 Bn
Dec 31, 2025 20.25 Bn
Sep 30, 2025 19.82 Bn
Jun 30, 2025 17.37 Bn
Mar 31, 2025 16.53 Bn
Dec 31, 2024 18.12 Bn
Sep 30, 2024 20.47 Bn
Jun 30, 2024 19.96 Bn
Mar 31, 2024 17.26 Bn
Dec 31, 2023 16.43 Bn
Sep 30, 2023 17.05 Bn
Jun 30, 2023 18.04 Bn
Mar 31, 2023 18.13 Bn
Dec 31, 2022 18.37 Bn
Sep 30, 2022 19.88 Bn
Jun 30, 2022 19.71 Bn
Mar 31, 2022 22.32 Bn
Jun 30, 2021 22.62 Bn
Mar 31, 2021 25.63 Bn
API Access

Takeda Pharmaceutical Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=TAK&period=max&api_key=YOUR_API_KEY